Concepedia

Author

Shu‐Nan Qi

Chinese Academy of Medical Sciences & Peking Union Medical CollegeORCID

Also Known As

S N Qi, S. Qi, S.N. Qi, Shu-Nan Qi, Shu-nan Qi, Shunan Qi, Shu‐Nan Qi, Songyu Qi, Tao Li, Y. Liu

68

Publications

1.2K

Citations

16

H-Index

20

Concepts

All Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical CollegeSun Yat-sen UniversityZhejiang Cancer HospitalFujian Provincial Cancer HospitalPeking Union Medical College Hospital
SQ

About

Shu‐Nan Qi is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

446

2

Immunology

2

2

59

3

Surgical Oncology

2

2

436

4

Health Sciences

1

1

387

5

Cell Biology

1

1

10

Shu‐Nan Qi

×

14

Publications

1K

Citations

13

H-Index

YearCitations

Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial

Shu-Lian Wang, Hui Fang, Yong-Wen Song,

The Lancet Oncology

2019

387

Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making

Si-Ye Chen, Yong Yang, Shu‐Nan Qi,

Leukemia

2020

125

Hypofractionated Versus Conventional Fractionated Radiotherapy After Breast-Conserving Surgery in the Modern Treatment Era: A Multicenter, Randomized Controlled Trial From China

Shu-Lian Wang, Hui Fang, Chen Hu,

Journal of Clinical Oncology

2020

105

Association of Improved Locoregional Control With Prolonged Survival in Early-Stage Extranodal Nasal-Type Natural Killer/T-Cell Lymphoma

Yong Yang, Jian-Zhong Cao, Shengmin Lan,

JAMA Oncology

2016

82

First-line non–anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG

Shu‐Nan Qi, Yong Yang, Yu-Qin Song,

Blood Advances

2020

56

Radiotherapy is essential after complete response to asparaginase-containing chemotherapy in early-stage extranodal nasal-type NK/T-cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG)

Xiu-Wen Deng, Jun-Xin Wu, Tao Wu,

Radiotherapy and Oncology

2018

49

Risk‐based, response‐adapted therapy for early‐stage extranodal nasal‐type <scp>NK</scp>/T‐cell lymphoma in the modern chemotherapy era: A China Lymphoma Collaborative Group study

Shu‐Nan Qi, Yong Yang, Yu Jing Zhang,

American Journal of Hematology

2020

47

Risk-Dependent Conditional Survival and Failure Hazard After Radiotherapy for Early-Stage Extranodal Natural Killer/T-Cell Lymphoma

Xin Liu, Tao Wu, Su-Yu Zhu,

JAMA Network Open

2019

45

Risk-adapted survival benefit of IMRT in early-stage NKTCL: a multicenter study from the China Lymphoma Collaborative Group

Tao Wu, Yong Yang, Su-Yu Zhu,

Blood Advances

2018

32

Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study

Yong Yang, Ying Wang, Xin Liu,

Leukemia

2020

30

Page 1